Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-22

Clinical Trial Update: Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on tipifarnib in combination chemotherapy for stage II/III breast cancer, including Phase 1 and Phase 2 results completed with posted find…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Male Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-22